Skip to content

epitalon

asset

2 claims involving it · 0 statements attributed to it

Involved in

The FDA advisory panel recommended that compounding pharmacies be allowed to manufacture the peptides epitalon and semax, and recommended against manufacturing emideltide.
On Friday, the panel voted 7-4 to add epitalon to the list for insomnia.

Statements attributed to it

Nothing in the record is attributed to this entity as a speaker.

Origin: first recognised while reading FDA advisory panel narrowly rejects compounding of one peptide, backs two others · 2026-09-11 07:34